Dear Reader, Markets were closed for President's Day, but I want to make sure you see this before tomorrow's opening bell. It's an in-depth discussion between Stansberry Research senior partner Dr. David "Doc" Eifrig and forensic accountant Joel Litman at Altimetry. Together, for the first time ever, they're sharing the details of what's known as a "special situation investment." It's an unusual moment in the market where the odds of success are HEAVILY weighted in your favor. And Joel and Doc are targeting a certain type of stock that could see 500% gains starting this year because of it. They aren't the only ones tracking this special situation, by the way. Doc's former employer Goldman Sachs, along with JPMorgan, are closely watching the same trend. In fact, they've created over two thousand new jobs to take advantage of what's happening. It's not AI, tech, or anything you've ever likely considered... Instead, it's a way to set yourself up to profit off ONE-THIRD of U.S. publicly traded companies right now. I'm sure you've heard a lot of folks talk about where the market is headed next, focusing on the Fed's next move or November's presidential election... But I guarantee you haven't heard this yet. Get the full story here. Regards, Matt Weinschenk
Director of Research, Stansberry Research P.S. As Doc's right-hand man for ten years, I know how selective he is about his collaborations. So when he teamed up with Joel Litman, I knew they must've found something extraordinary for you. Make sure you see this BEFORE tomorrow's opening bell. | 
No comments:
Post a Comment
Keep a civil tongue.